Bruce Peter Connop,Dorothy Melissa Lynn Spencer,Jagatraj Singh,Pawel Dominik Buczek,Cale Michael Halbleib,Donald Edmund Kerkow
申请号：
US16698329
公开号：
US20200262887A1
申请日:
2019.11.27
申请国别(地区):
US
年份:
2020
代理人:
摘要：
The present invention relates to GLP-1 and/or glucagon receptor agonists (for example, oxyntomodulin peptide analogs), pharmaceutically acceptable salts thereof, formulations comprising the same, and uses thereof for treating diabetes and/or obesity or associated diseases or disorders.
